SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
SS
Lv5
1425 积分
2021-02-17 加入
最近求助
最近应助
互助留言
A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy
1个月前
已完结
RESEARCH ARTICLE|ARTICLES IN PRESS Purchase Subscribe Save Share Reprints Request Effect of Nusinersen Treatment on Quality of Life and Motor Function in Adult Patients with Spinal Muscular Atrophy
3个月前
已完结
Impact of nusinersen on the health-related quality of life and caregiver burden of patients with spinal muscular atrophy with symptom onset after age 6 months
5个月前
已完结
A new score combining compound muscle action potential (CMAP) amplitudes and motor score is predictive of motor outcome after AVXS-101 (Onasemnogene Abeparvovec) SMA therapy
9个月前
已完结
Use of the assessment of caregiver experience with neuromuscular disease (ACEND with SMA) - a caregiver experience from a single center
1年前
已完结
Systematic Review of Motor Function Scales and Patient-Reported Outcomes in Spinal Muscular Atrophy
1年前
已完结
Real-World Data: Risdiplam (Evrysdi) in Three Patients with SMA Type II: Single-Center Experiences
1年前
已关闭
Assessment of Bulbar Function in Adult Patients with 5q-SMA Type 2 and 3 under Treatment with Nusinersen
1年前
已完结
How children and caregivers viewed the change from nusinersen to risdiplam for treating spinal muscular atrophy
1年前
已完结
New results for risdiplam in spinal muscular atrophy
1年前
已完结
没有进行任何应助
感谢,点赞,速度真快
1个月前
点赞
3个月前
感谢
5个月前
感谢,点赞
9个月前
感谢
1年前
点赞
1年前
点赞
1年前
积分太高【积分已退回】
1年前
感谢
1年前
点赞,感谢
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论